It finalizes the revised draft guidance for industry Liposome Drug Products, Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentationthat ...

As of 2023, there have been 15 liposomal drug products approved by the FDA, and their indications include a wide range of applications including cancer treatments, vaccines, infections, and pain …

CD Bioparticles organizes and provides a list of nano-drugs that have been approved by the FDA and EMA for marketing and clinical research in recent years for reference in new drug development.

Jan 4, 2025 · Notable examples of FDA-approved nanoparticle therapies include liposome-based Doxil, DaunoXome, Marqibo, Onpattro, and Vyxeos.

Sep 10, 2025 · Learn how to navigate FDA nanomedicine regulations with guidance documents, market insights, and global strategies for successful development.

Nov 23, 2025 · Explore the diverse range of FDA approved liposome formulation drugs, from cancer treatments like Doxil to pain relievers like Exparel, and their therapeutic benefits.

Sep 15, 2021 · The DailyMed database contains 155329 labeling submitted to the Food and Drug Administration (FDA) by companies. DailyMed does not contain a complete listing of labeling for FDA …

Jun 24, 2022 · This chapter focuses on the product quality tests that are generally necessary for liposomal preparations as well as selected specific requirements for liposomes not mentioned by …

May 19, 2025 · Congressional offices may consult the FDA’s catalog of databases to identify information on a medical device or drug’s current status in the United States. The data collected in these …

Apr 19, 2022 · This review aims to provide updated information about various approved and marketed liposome formulations and their role in the modern-day health care systems. Keywords: Liposomes, …